BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, announced today ...

Teachers in Washington state’s Peninsula school district seeking critical feedback on their instruction have a new tool to ...

Officials and experts in Argentina are scrambling to figure out if their country is the source of a deadly hantavirus outbreak that has gripped an Atlantic cruise. Argentina is consistently ...

JavaScript DOM manipulation is the backbone of creating dynamic, interactive web pages. From selecting elements to handling events and fetching data, mastering these skills transforms static HTML into ...

WebFX reports that Google Analytics 4 data is often unreliable, missing insights due to browser blocks, impacting marketing decisions.

Somehow the centre-right managed, while the left did not. De redactie van NRC selecteert de beste artikelen uit The Economist ...

"It's OK to acknowledge when you were wrong." ...

In the annual management reports of fund performance, several Vanguard ETFs attribute returns lagging benchmarks in part to “other miscellaneous factors.” Where can an investor find out what these are ...

AstraZeneca and Ionis are set fair for EU approval of Wainzua, their treatment for polyneuropathy associated with transthyretin-mediated amyloidosis (ATTR), after the EMA's human medicines committee ...

AstraZeneca and Ionis Pharma have an EU green light for their Wainzua therapy for hereditary transthyretin-mediated amyloidosis (ATTR) polyneuropathy, building on earlier approvals in the US and UK ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. The Food and Drug ...